PACB
Pacific Biosciences of California
2.90$
+13.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 4,741.7% | 62,297.0% | 8,168.9% | 61.5% | 96.4% | 77.2% | 61.4% | 42.4% | 51.3% | 62.9% | 68.1% | 62.0% | 58.7% | 54.9% | 61.8% | 73.7% | 75.8% | 68.3% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 38.5% | 3.6% | 22.8% | 38.6% | 57.6% | 48.7% | 37.1% | 31.9% | 38.0% | 41.3% | 45.1% | 38.2% | 26.3% | 24.2% | 31.7% | |
| 888.4% | 4,217.2% | 56,206.7% | 6,679.9% | 224.7% | 183.3% | 160.5% | 79.6% | 65.1% | 74.5% | 69.9% | 79.6% | 65.6% | 81.3% | 86.5% | 150.4% | 93.3% | 87.6% | 60.8% | |
| – | – | – | 1,797.3% | 137.9% | 183.4% | 137.5% | 62.8% | 48.7% | 52.7% | 63.3% | 80.7% | 83.1% | 92.3% | 95.1% | 125.4% | 84.2% | 113.6% | 88.4% | |
| 1,181.4% | 5,073.3% | 65,337.0% | 8,477.2% | 362.6% | 366.7% | 297.9% | 142.4% | 113.8% | 127.2% | 133.1% | 160.4% | 148.7% | 173.6% | 206.3% | 277.6% | 193.1% | 332.2% | 380.1% | |
| -1,081.4% | -4,973.3% | -65,237.0% | -8,377.2% | -324.1% | -363.1% | -275.2% | -103.7% | -31.4% | -78.5% | -96.1% | -128.4% | -110.6% | -132.3% | -161.2% | -239.4% | -166.8% | -308.0% | -348.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.8% | 1.1% | 8.8% | 4.7% | 3.2% | 3.6% | 3.1% | 3.1% | 2.9% | 0.3% | 9.6% | 11.4% | 7.2% | 8.7% | 4.3% | |
| -994.8% | -4,856.2% | -64,965.2% | -8,373.1% | -323.0% | -363.6% | -281.4% | -109.2% | -34.2% | -82.0% | -98.6% | -130.4% | -92.6% | 37.3% | -210.6% | -244.9% | -158.7% | -201.0% | -341.3% | |
| -89.7% | -128.4% | -334.1% | -10.3% | -1.1% | 0.0% | 11.4% | 3.9% | -0.4% | 3.7% | -5.4% | 1.1% | -6.9% | -8.8% | -71.8% | -13.5% | -5.7% | 0.2% | 0.2% | |
| -994.8% | -4,856.2% | -64,965.2% | -8,373.1% | -323.0% | -363.6% | -281.4% | -109.2% | -34.2% | -82.0% | -98.6% | -130.4% | -92.6% | 37.3% | -138.9% | -244.9% | -153.0% | -201.2% | -341.5% | |
| -1,008.5% | -4,641.7% | -62,197.0% | -8,064.9% | -305.0% | -336.8% | -252.5% | -97.6% | -27.0% | -74.2% | -86.5% | -118.2% | -78.7% | 49.4% | -192.1% | -220.0% | -135.2% | -157.6% | -21.4% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.